Lin Meng, Ph.D.

Postdoctoral Scholar – Research Associate
Center for Craniofacial Molecular Biology
Herman Ostrow School of Dentistry of USC

2250 Alcazar St.
CSA 140 – HSC 9062
Los Angeles, CA 90033-9062
Phone: (323) 442-3170
Fax: (323) 442-2981
lmeng500@usc.edu

Education
Experience
Publications

Jilin University, School and Hospital of Stomatology, Changchun City, China
B.S., 2016

Jilin University, School and Hospital of Stomatology, Changchun City, China
M.S., 2019

Jilin University, School and Hospital of Stomatology, Changchun City, China
Ph.D., 2022

  • 2022 – Present – Postdoctoral Scholar – Research Associate – Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA

  1. Zhou D, Chen Y, Bu W, Meng L, Wang C, Jin N, Chen Y, Ren C, Zhang K, Sun H. (2021) Modification of Metal-Organic Framework Nanoparticles Using Dental Pulp Mesenchymal Stem Cell Membranes to Target Oral Squamous Cell Carcinoma. J Colloid Interface Sci. 2021 Nov;601:650-660. doi: 10.1016/j.jcis.2021.05.126. Epub 2021 May 24. PMID: 34091312.

  2. Zhao Y, Meng L, Zhang K, Sun Y, Zhao Y, Yang Z, Lin Y, Liu X, Sun H, Yang B, Lin Q. (2021) Ultra-small nanodots coated with oligopeptides providing highly negative charges to enhance osteogenic differentiation of hBMSCs better than osteogenic induction medium. Chinese Chemical Letters, Volume 32, Issue 1, 2021, Pages 266-270, ISSN 1001-8417, https://doi.org/10.1016/j.cclet.2020.10.031.

  3. Ren C, Hao X, Wang L, Hu Y, Meng L, Zheng S, Ren F, Bu W, Wang H, Li D, Zhang K, Sun H. (2021) Metformin Carbon Dots for Promoting Periodontal Bone Regeneration via Activation of ERK/AMPK Pathway. Adv Healthc Mater. 2021 Jun;10(12):e2100196. doi: 10.1002/adhm.202100196. Epub 2021 May 14. PMID: 33987977.

  4. Jin N, Jin N, Wang Z, Liu L, Meng L, Li D, Li X, Zhou D, Liu J, Bu W, Sun H, Yang B. (2020) Osteopromotive carbon dots promote bone regeneration through the PERK-eIF2α-ATF4 pathway. Biomater Sci. 2020 May 19;8(10):2840-2852. doi: 10.1039/d0bm00424c. PMID: 32307492.

  5. Meng L, Zhao Y, Bu W, Li X, Liu X, Zhou D, Chen Y, Zheng S, Lin Q, Liu Q, Sun H. (2020) Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma. Cell Prolif. 2020 Aug;53(8):e12859. doi: 10.1111/cpr.12859. Epub 2020 Jun 26. PMID: 32588946; PMCID: PMC7445409.

  6. Liu X, Meng L, Li X, Li D, Liu Q, Chen Y, Li X, Bu W, Sun H. (2020) Regulation of FN1 degradation by the p62/SQSTM1-dependent autophagy-lysosome pathway in HNSCC. Int J Oral Sci. 2020 Dec 14;12(1):34. doi: 10.1038/s41368-020-00101-5. Erratum in: Int J Oral Sci. 2021 Nov 2;13(1):34. doi: 10.1038/s41368-021-00139-z. PMID: 33318468; PMCID: PMC7736930.

  7. Bu W, Wang Z, Meng L, Li X, Liu X, Chen Y, Xin Y, Li B, Sun H. (2019) Disulfiram inhibits epithelial-mesenchymal transition through TGFβ-ERK-Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis. Cancer Manag Res. 2019 May 1;11:3887-3898. doi: 10.2147/CMAR.S199912. Erratum in: Cancer Manag Res. 2019 May 22;11:4617. doi: 10.2147/CMAR.S214609. Erratum in: Cancer Manag Res. 2021 Nov 25;13:8647-8650. doi: 10.2147/CMAR.S348759. PMID: 31118804; PMCID: PMC6504671.

  8. Li X, Bu W, Meng L, Liu X, Wang S, Jiang L, Ren M, Fan Y, Sun H. (2019) CXCL12/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC. Exp Cell Res. 2019 May 15;378(2):131-138. doi: 10.1016/j.yexcr.2019.03.013. Epub 2019 Mar 8. PMID: 30857971.

  9. Wang D, Xu X, Zhang K, Sun B, Wang L, Meng L, Liu Q, Zheng C, Yang B, Sun H. (2017) Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment. Int J Nanomedicine. 2017 Dec 28;13:187-198. doi: 10.2147/IJN.S150610. Erratum in: Int J Nanomedicine. 2021 Dec 01;16:7859-7860. doi: 10.2147/IJN.S349851. PMID: 29343957; PMCID: PMC5749394.

  10. Li X, Chang B, Wang B, Bu W, Zhao L, Liu J, Meng L, Wang L, Xin Y, Wang D, Tang Q, Zheng C, Sun H. (2017) Rapamycin promotes osteogenesis under inflammatory conditions. Mol Med Rep. 2017 Dec;16(6):8923-8929. doi: 10.3892/mmr.2017.7693. Epub 2017 Oct 3. PMID: 28990080; PMCID: PMC5779975.